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 Special Section: Moving Forward in Animal Research Ethics 
 Guest Editorial 
 Reassessing Animal Research Ethics 
 DAVID  DeGRAZIA and  TOM L.  BEAUCHAMP 
 Animal research has long been a source of biomedical aspirations and moral con-
cern. Examples of both hope and concern are abundant today. In recent months, as 
is common practice, monkeys have served as test subjects in promising preclinical 
trials for an Ebola vaccine or treatment  1 , 2 , 3  and in controversial maternal depriva-
tion studies.  4  The unresolved tension between the noble aspirations of animal 
research and the ethical controversies it often generates motivates the present 
issue of the  Cambridge Quarterly of Healthcare Ethics . 
 As editors of this special section, we hope that these original and timely articles 
will push the professional discussion of animal research ethics in a positive direc-
tion that will benefi t research scientists and others interested in moral problems in 
animal research. We also look forward to a day when animal research will genu-
inely meet both appropriate scientifi c and appropriate ethical criteria—criteria 
that themselves can be improved by critical scrutiny. 
 Animal research—that is, the use of live animals as experimental subjects in 
biomedical and behavioral fi elds of learning—has been deeply entrenched for 
well over half a century. One signal development was the enactment in the late 
1930s of federal product safety legislation in the United States and other nations 
that  required animal testing of food, drugs, and medical devices prior to use by human 
subjects or consumers.  5  Another development was the publication of codes of 
research ethics that called for animal research prior to human research. The 
Nuremberg Code, published by an American military tribunal in 1947–48 after scru-
tiny of Nazi medical atrocities, stated that experiments involving the use of human 
subjects should be “based on the results of animal experimentation.”  6  The Declaration 
of Helsinki, fi rst published in 1964, reaffi rmed this assumption and added, rather 
imprecisely, that “the welfare of animals used for research must be respected.”  7  
 Against the background of such statements, the institutionalization and 
widespread acceptance of animal research in the twentieth century rested on 
two basic assumptions, one factual and one moral. The  factual assumption was that 
animal research is suffi ciently reliable as a basis for predicting the effects of 
drugs, products, and other materials on human beings that animal trials can be 
expected to yield signifi cant scientifi c conclusions and medical benefi ts to humanity. 
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Animal research was viewed as protecting human subjects from unnecessary 
research risks and providing information vital to the advancement of biomedical 
science. The  moral assumption was that the moral status of animals is inferior to the 
moral status of human beings—a thesis commonly expressed in the language of 
“human dignity.” 
 This moral assumption helps explain why many have thought it relatively easy 
to defend the involvement of animal subjects in conditions and procedures that 
often seriously harm them and where anticipated benefi ts are nearly always for 
the sake of humanity rather than the animal subjects. Signifi cantly harmful, non-
therapeutic research on human beings without their consent is a paradigm of 
unethical research, as exemplifi ed by the Nazi medical atrocities. Thus the moral 
acceptability of such research involving animal subjects requires the assumption 
that their moral status is exceeded by the moral status of human beings—or 
requires some related assumption such as the claim that humans have rights or 
dignity, whereas nonhuman animals do not. 
 Both of the above-mentioned pivotal and widely believed assumptions are now 
increasingly called into question. Several of the articles in the present volume 
attempt to illuminate some aspect of animal research ethics without taking a defi -
nite stand on either of the contested assumptions. But other articles criticize some 
aspect of these and related assumptions. 
 The package of articles commences with Hope Ferdowsian and John Gluck’s 
“The Ethical Challenges of Animal Research: Honoring Henry Beecher’s Approach 
to Moral Problems.” With his 1966 article “Ethics and Clinical Research,” Henry K. 
Beecher signifi cantly advanced the cause of human research protections by expos-
ing multiple ethical defi ciencies in human subjects research.  8  His infl uential con-
tribution was to demonstrate that unethical practices were far more common than 
was generally appreciated at the time. Ferdowsian and Gluck argue that numer-
ous problems with animal research as currently practiced, including a dearth of 
rigorous ethical evaluation, are analogous to the problems in human research to 
which Beecher called attention. These authors describe cases that illustrate what 
they believe to be sobering ethical shortcomings in the conduct of animal research. 
They conclude by offering a set of recommendations that address some of the defi -
cits on which they focus. 
 In the second article in this special issue, “The Flaws and Human Harms of 
Animal Experimentation,” Aysha Akhtar bluntly challenges the factual assump-
tion that animals provide reliable models for human responses, disease, and 
biology. She points to a growing body of scientifi c literature that critically exam-
ines the performance of animal modeling (and of animal experimentation more 
generally) and raises concerns about its value for predicting human outcomes 
and for insights into human physiology. She argues that empirical studies of the 
unreliability of animal experimentation across a wide range of types of research 
undermine scientifi c arguments in support of this work. Akhtar also argues 
that animal experimentation often imposes signifi cant harms on human beings 
through misleading safety studies, abandonment of potentially effective thera-
pies, and diversion of resources away from more effective testing methods. The 
picture she presents is one in which the collective harms and costs to human 
beings from animal research generally outweigh potential benefi ts. She concludes 
that resources would be better invested if redirected to the development and use 
of human-based testing methods. 
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 In the third article, “Necessary Conditions for Morally Responsible Animal 
Research,” David DeGrazia and Jeff Sebo present a nuanced position with respect 
to the pivotal moral and factual assumptions undergirding the mainstream justifi -
cation of animal research. First, they assume that the moral assumption that 
human beings have higher moral status than animals is true. This assumption 
permits them to address proponents of animal research who make the same 
assumption and are also disposed to take seriously the ethical issues generated by 
animal research. From this common ground, the authors argue that several condi-
tions are necessary for animal research to be morally justifi ed. The fi rst condition, 
the expectation of suffi cient net benefi t, effectively incorporates the pivotal factual 
assumption that animal testing is reliable and productive. Remaining agnostic on 
the truth of this assumption, the authors argue that the expectation of suffi cient 
net benefi t is not particularly controversial but must be satisfi ed. DeGrazia and Sebo 
also defend what they call a worthwhile-life condition and a no-unnecessary-
harm/qualifi ed-basic-needs condition for justifi ed animal research. They argue 
that, whether or not these necessary conditions are  jointly sufﬁ cient for justifi ed 
animal research, they are demanding, with the implication that much animal 
research as currently practiced may fail to satisfy them. 
 Another arguably necessary condition of morally responsible animal research is 
the placement of an upper limit on the pain, distress, or suffering that animal sub-
jects may undergo. If such a limit is appropriate, then animal trials that exceed it 
are morally unjustifi ed. In “The Upper Limits of Pain and Suffering in Animal 
Research: A Moral Assessment of the European Union’s Legislative Framework,” 
Tom L. Beauchamp and David B. Morton propose that a ceiling be placed on expe-
riential harm. They assess the merits of perhaps the most important statement in 
the current literature on upper limits, namely, the European Directive 2010/63/
EU on the Protection of Animals Used for Scientifi c Purposes. The authors con-
tend that this legislation governing animal research in the European Union shows 
considerable promise but also needs improvements. Beauchamp and Morton offer 
a moral rationale for the incorporation of upper-limit guidelines and legislation 
and then address the complicated problem of whether exceptions to this necessary 
condition should be allowed. They advance several reasons why revision of the 
EU directive is needed while maintaining that this European legislation, suitably 
revised, could have a substantial and salubrious infl uence on the conduct of 
animal research worldwide. 
 Animals are used as research subjects for a variety of purposes, most falling 
under one or more of four categories: basic biological research; the study of human 
disease; the search for effective medicines; and safety testing of medicines, chemi-
cals, cosmetics, and other products. In “Ending the Use of Animals in Toxicity 
Testing and Risk Evaluation,” Andrew Rowan focuses on safety testing, with spe-
cial attention to recent and future developments in toxicology. He provides a his-
tory of developments in safety testing technology and explores the implications of 
several developments in industry, public policy, public health, economics, and 
ethics. A striking feature of Rowan’s analysis is its evidence-based challenge to the 
factual assumption underlying the justifi cation of animal research—namely, that 
animal models are reliable. Rowan maintains that the predictive value of animal 
testing appears to be, typically, in the range of 50–60 percent accurate,  9  but the 
predictive value in rodent-only studies appears to fall below 50 percent (less accu-
rate than a coin toss).  10  More positively, he describes the Environmental Protection 
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Agency’s ToxCast program,  11  an alternative to animal testing, as comparable in 
accuracy to the animal tests that have emerged after 80 years of attempted improve-
ments. He fi nds good reason to believe that this and other nonanimal testing pro-
grams will continue to improve, allowing the discontinuation of animal testing 
and resulting in savings in time, money, and animal welfare, without cost in pre-
dictive power. 
 In the fi nal article, “Is There a Role for Assent or Dissent in Animal Research?,” 
Holly Kantin and David Wendler start with the fact that in the context of pediatric 
research, children who presumptively cannot provide  informed consent (or  refusal ) 
may nonetheless have preferences about participation that matter morally. If they 
have any signifi cant capacity to understand what participation involves, their 
 assent must be solicited. If they balk at participating, their dissent must be respected 
unless entering a protocol is in their medical best interests. Like children, animals 
are incapable of providing informed consent but often have preferences regarding 
participation in research. Kantin and Wendler then consider whether animal sub-
jects can nonverbally assent or dissent in a meaningful way. They fi nd welfare-
based reasons for investigators to consider and in some cases respect the dissent 
of animal research subjects who behaviorally express dissent. They also fi nd 
empirical grounds for believing that agency-based reasons apply to chimpanzees, 
and supply a rationale for the U.S. Institute of Medicine’s ground-breaking recom-
mendation that comparative genomics and behavioral research with chimpanzees 
should be conducted only if they “acquiesce” to participation.  12  
 As the articles in this special section indicate, scholars in bioethics from several 
disciplines have come to regard various problems of animal research as resolvable 
either by tailoring existing human research requirements to fi t the animal research 
context or by creating new protections for animals that satisfy what are arguably 
necessary conditions of morally justifi ed animal research. The importance of this 
work has fi nally gained recognition in bioethics, where it had stirred up little 
notice for decades. We hope the contributions in this journal issue will continue 
the trend to ethical analysis of animal research, thereby bringing animal research 
a notch closer to the more settled domains within bioethics and research ethics. 
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